Utility of Whole-Body Magnetic Resonance Imaging Surveillance in Children and Adults With Cancer Predisposition Syndromes: A Retrospective Study
JCO Precision Oncology · 2025
DOI: 10.1200/po-24-00642 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2025. Verfasst von Frances Victoria Fajardo Que und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore, Singapore. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Whole Body Imaging, Neoplastic Syndromes, Hereditary. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
PURPOSE Surveillance improves patient outcomes by diagnosing cancer at an early and curable stage for individuals with cancer predisposition syndromes (CPS). Whole-body magnetic resonance imaging (WB-MRI) provides head-to-thigh imaging in one sitting without radiation exposure and is recommended for individuals with increased risk of multisite tumors or cancers. In this study, we evaluated the diagnostic performance of WB-MRI as a screening tool for Li-Fraumeni syndrome (LFS), constitutional mismatch repair deficiency syndrome, hereditary paraganglioma-pheochromocytoma syndrome (HPGL-PCC), and other CPS. METHODS A retrospective review of patients with CPS seen at the Cancer Genetics Service, National Cancer Center Singapore was conducted. Patients who underwent WB-MRI screening from 2014 to 2024 were identified to determine the sensitivity and specificity of WB-MRI in early cancer detection. RESULTS Of the 103 patients with CPS recommended for WB-MRI surveillance, 59 underwent the procedure (57% uptake rate). Among them, 34 (57%) were female and the median age was 32 years (range, 1-74 years). The CPS distributions included 22 (37%) with LFS, 14 (24%) with neurofibromatosis type 1, eight (14%) with Von Hippel Lindau syndrome, and eight (14%) with HPGL-PCC. WB-MRI screening led to a diagnosis of cancer in seven (12%) patients (renal cell carcinoma, prostate adenocarcinoma, osteosarcoma, neuroendocrine tumor); of these, four (57%) received curative treatment. Twelve (20%) patients required additional investigations, with eight (14%) having benign findings. The sensitivity and specificity of WB-MRI in our cohort were 64% and 92%, respectively, with a false-positive rate (FPR) of 8% and a false-negative rate of 36%. CONCLUSION WB-MRI is an effective screening tool in patients with specific CPS, demonstrating a high specificity and low FPR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre Singapore, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
- Division of Oncologic Imaging, National Cancer Centre Singapore, Singapore.
ORCID-Profile: Frances Victoria Fajardo Que, Jeanette Yuen, Zewen Zhang, Jianbang Chiang, Choon Hua Thng, Joanne Ngeow
Zitieren
APA
Que, F. V. F., Ishak, N. D. B., Li, S. T., Yuen, J., Shaw, T., Goh, H. X., Zhang, Z., Chiang, J., Yeo, S. Y., Chew, L. L., Thng, C. H., & Ngeow, J. (2025). Utility of Whole-Body Magnetic Resonance Imaging Surveillance in Children and Adults With Cancer Predisposition Syndromes: A Retrospective Study. JCO Precision Oncology. https://doi.org/10.1200/po-24-00642
Vancouver
Que FVF, Ishak NDB, Li ST, Yuen J, Shaw T, Goh HX, et al. Utility of Whole-Body Magnetic Resonance Imaging Surveillance in Children and Adults With Cancer Predisposition Syndromes: A Retrospective Study. JCO Precision Oncology. 2025. doi:10.1200/po-24-00642
BibTeX
@article{Que2025,
author = {Que, Frances Victoria Fajardo and Ishak, Nur Diana Binte and Li, Shao-Tzu and Yuen, Jeanette and Shaw, Tarryn and Goh, Hui Xuan and Zhang, Zewen and Chiang, Jianbang and Yeo, Si Yong and Chew, Lee Lian and Thng, Choon Hua and Ngeow, Joanne},
title = {Utility of Whole-Body Magnetic Resonance Imaging Surveillance in Children and Adults With Cancer Predisposition Syndromes: A Retrospective Study},
journal = {JCO Precision Oncology},
year = {2025},
doi = {10.1200/po-24-00642}
}
EUVIMED